Clinical Trials on SARS-CoV-2 Acute Respiratory Disease in New Zealand
Total 410 results
-
Syneos HealthUS Specialty Formulations, LLCCompletedSARS-CoV-2 (COVID-19)New Zealand
-
NeuroActiva, Inc.Biomed Industries, Inc.UnknownCovid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)New Zealand, United States
-
BioNTech SECompletedCOVID-19 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | SARS (Disease)United States, Germany, Turkey, South Africa
-
Vaccine Company, Inc.Active, not recruitingSARS-CoV-2 | SARS-CoVUnited States
-
NYU Langone HealthRecruitingNeuropsychiatric Post-Acute Sequelae of SARS-CoV-2 InfectionUnited States
-
Chinese University of Hong KongCompletedIntention to Get SARS-CoV-2 Vaccination | Intention to Get SARS-CoV-2 Antibody TestHong Kong
-
Institut PasteurCentre Hospitalier Territorial de Nouvelle-Calédonie; Centre Hospitalier Spécialisé... and other collaboratorsCompletedSARS-CoV-2 Acute Respiratory DiseaseNew Caledonia
-
Valneva Austria GmbHCompleted
-
Yale UniversityCompletedSARS-CoV-2United States
-
ModernaTX, Inc.CompletedSARS-CoV-2United States
-
ModernaTX, Inc.Aetion, Inc.Active, not recruiting
-
ModernaTX, Inc.CompletedSARS-CoV-2United States
-
Rutgers, The State University of New JerseyUniversity Hospital - Newark, NJNo longer availableCOVID-19 | SARS-CoV 2 | SARS-CoV InfectionUnited States
-
DurectTerminatedSARS-CoV-2United States
-
Johns Hopkins UniversityNational Institute of Allergy and Infectious Diseases (NIAID); United States... and other collaboratorsCompletedSARS-CoV 2United States
-
ModernaTX, Inc.Completed
-
Tonix Pharmaceuticals, Inc.CompletedCOVID-19 | Long COVID | Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection | Long Haul COVIDUnited States
-
ModernaTX, Inc.Recruiting
-
Tonix Pharmaceuticals, Inc.Premier Research Group plcActive, not recruitingDetection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2United States
-
ModernaTX, Inc.National Institute of Allergy and Infectious Diseases (NIAID); Biomedical Advanced...Completed
-
ModernaTX, Inc.Completed
-
Valneva Austria GmbHCompletedSARS-CoV-2 InfectionNew Zealand, Netherlands
-
ModernaTX, Inc.Biomedical Advanced Research and Development AuthorityActive, not recruitingSARS-CoV-2United States, Dominican Republic
-
ModernaTX, Inc.Completed
-
ModernaTX, Inc.RecruitingSARS-CoV-2United States, Puerto Rico
-
AstraZenecaActive, not recruitingSARS-CoV-2United States, Belgium, United Kingdom, Brazil, Germany
-
Rutgers, The State University of New JerseyNational Institute of Dental and Craniofacial Research (NIDCR)Completed
-
Rutgers, The State University of New JerseyNational Institute of Dental and Craniofacial Research (NIDCR)CompletedSARS-CoV2 InfectionUnited States
-
Memorial Sloan Kettering Cancer CenterWithdrawnCOVID-19 | COVID19 | Sars-CoV2 | SARS-Cov-2United States
-
NYU Langone HealthRecruitingCOVID-19 | SARS CoV 2 InfectionUnited States
-
Rutgers, The State University of New JerseyNational Institute of Dental and Craniofacial Research (NIDCR)Completed
-
ModernaTX, Inc.Completed
-
TScan Therapeutics, Inc.CompletedIdentify the Viral Epitopes of Memory CD8 T Cells From Individuals That Have Recovered From SARS-CoV-2 Infection | Determine Which SARS-CoV-2 Proteins Are Frequently Recognized by T Cells in Patients With Varying HLA TypesUnited States
-
Swedish Orphan BiovitrumTerminated
-
MiCo BioMed Co., Ltd.SyntactxCompletedSARS-CoV2 InfectionUnited States
-
University of WashingtonBill and Melinda Gates FoundationCompletedCOVID-19 | Corona Virus Infection | SARS-CoV-2 | SARS (Severe Acute Respiratory Syndrome)United States
-
Leidos Life SciencesUnited States Department of DefenseTerminatedCOVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV InfectionUnited States
-
PfizerCompletedCovid-19 | Immunocompromised | Breakthrough Infection | SARS-COV-2 Infection | SARS-COV-2 | ImmunosuppressedUnited States
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSARS-CoV2 InfectionUnited States, Puerto Rico
-
BioNTech SEPfizerCompletedSARS-CoV-2 Infection, COVID19United States, Brazil, Germany, Mexico
-
Tulane UniversityNational Institutes of Health (NIH)Active, not recruitingAsthma | Bronchiolitis | Respiratory Syncytial Virus (RSV) | SARS CoV 2 InfectionUnited States
-
Davita Clinical ResearchCompletedSARS-CoV-2 Infection | Anti-SARS-CoV-2 InfectionUnited States
-
University of MelbourneThe George Institute; The University of Queensland; The Peter Doherty Institute... and other collaboratorsRecruitingSARS-CoV-2 Infection (COVID-19)Australia
-
BioNTech SEPfizerRecruitingCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | SARS-CoV-2 VirusUnited States, Brazil, Puerto Rico
-
Davita Clinical ResearchCompletedSARS-CoV-2 Infection (Asymptomatic) | SARS-CoV-2 Infection (Symptomatic)United States
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionAustralia, New Zealand
-
PfizerCompletedCOVID-19 | SARS-CoV-2 InfectionAustralia, New Zealand
-
Rutgers, The State University of New JerseyActive, not recruiting
-
Gilead SciencesApproved for marketingSARS-CoV2 InfectionUnited States, Israel, Belgium, Spain, Australia, Denmark, Italy, Germany, France, Portugal, United Kingdom, Poland, Switzerland, Canada, Austria, Cyprus, Czechia, Estonia, Greece, Hungary, Iceland, Ireland, Lithuania, Netherlands, Romania and more
-
PfizerWithdrawnSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Disease 2019 (COVID-19) | Immunocompromised | Hospitalization | Child, HospitalizedUnited States, Bulgaria